ER&#945; is an RNA-binding protein sustaining tumor cell survival and drug resistance.

Xu, Yichen; Huangyang, Peiwei; Wang, Ying; Xue, Lingru; Devericks, Emily; Nguyen, Hao G; Yu, Xiuyan; Oses-Prieto, Juan A; Burlingame, Alma L; Miglani, Sohit; Goodarzi, Hani; Ruggero, Davide

ERα is an RNA-binding protein sustaining tumor cell survival and drug resistance.

Xu, Yichen; Huangyang, Peiwei; Wang, Ying; Xue, Lingru; Devericks, Emily; Nguyen, Hao G; Yu, Xiuyan; Oses-Prieto, Juan A; Burlingame, Alma L; Miglani, Sohit; Goodarzi, Hani; Ruggero, Davide.

Affiliation

Xu Y; Department of Urology, University of California, San Francisco, San Francisco, CA 94158, USA; Institute of Pharmacology and Toxicology, College of Pharmaceutical Sciences, Zhejiang University, Hangzhou 310058, China.
Huangyang P; Department of Urology, University of California, San Francisco, San Francisco, CA 94158, USA; Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, CA 94158, USA.
Wang Y; Department of Urology, University of California, San Francisco, San Francisco, CA 94158, USA; Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, CA 94158, USA.
Xue L; Department of Urology, University of California, San Francisco, San Francisco, CA 94158, USA; Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, CA 94158, USA.
Devericks E; Department of Urology, University of California, San Francisco, San Francisco, CA 94158, USA; Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, CA 94158, USA.
Nguyen HG; Department of Urology, University of California, San Francisco, San Francisco, CA 94158, USA; Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, CA 94158, USA.
Yu X; Department of Breast Surgery, Second Affiliated Hospital, Zhejiang University School of Medicine, Zhejiang University, Hangzhou 310009, China.
Oses-Prieto JA; Department of Pharmaceutical Chemistry, University of California, San Francisco, San Francisco, CA 94158, USA.
Burlingame AL; Department of Pharmaceutical Chemistry, University of California, San Francisco, San Francisco, CA 94158, USA.
Miglani S; Department of Urology, University of California, San Francisco, San Francisco, CA 94158, USA; Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, CA 94158, USA; Department of Biochemistry & Biophysics, University of California, San Francisco,
Goodarzi H; Department of Urology, University of California, San Francisco, San Francisco, CA 94158, USA; Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, CA 94158, USA; Department of Biochemistry & Biophysics, University of California, San Francisco,
Ruggero D; Department of Urology, University of California, San Francisco, San Francisco, CA 94158, USA; Department of Cellular and Molecular Pharmacology, University of California, San Francisco, San Francisco, CA 94158, USA; Helen Diller Family Comprehensive Cancer Center, University of California, San Franc

Cell ; 184(20): 5215-5229.e17, 2021 09 30.

Article de En | MEDLINE | ID: mdl-34559986

Sujet(s)
Mots clés

ERα; RNA splicing; RNA-binding protein; breast cancer; cell survival; integrated stress response; translation control

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Tumeurs du sein / Protéines de liaison à l'ARN / Résistance aux médicaments antinéoplasiques / Récepteur alpha des oestrogènes Limites: Animals / Female / Humans Langue: En Journal: Cell Année: 2021 Type de document: Article Pays d'affiliation: Chine Pays de publication: États-Unis d'Amérique

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google